Piper Tirzepatide Review: Cost & Honest Verdict (2026)

Piper is a telehealth weight-loss provider offering aggressively low compounded GLP-1 pricing to all 50 states, but the ranking's own research found very limited public information on program details beyond pricing and molecule availability. Every fact here comes from the company's own published program.

What Piper is

Piper is a telehealth weight-loss provider, offering both compounded semaglutide and tirzepatide to all 50 states, with an online intake reviewed by a licensed clinician.

What Piper costs

Tirzepatide starts at $199/month for the starting dose — an aggressively low rate relative to the wider market.

The brand-vs-compounded question

Piper dispenses compounded semaglutide and tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Piper's real strengths: aggressively low monthly pricing, both semaglutide and tirzepatide available, and all-50-state coverage. The trade-off is significant, and this review flags it directly: very limited public information on program specifics beyond pricing and molecule availability — no named compounding pharmacy, no accreditation badge, and no named clinical leadership were found. As with any GLP-1 program, and especially one this thin on public disclosure at an aggressively low price, ask directly about pharmacy sourcing before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Piper's aggressive starting price is a real hook, but this review found very little else to verify — no named pharmacy and no accreditation badge. Ask directly before committing. For a provider with fuller public disclosure at a similar price, compare it against MyFastRx or NewSelf. See our best tirzepatide providers ranking for the full field.